Case Study: Pediatric Uvular Cyst
When an 18-month-old patient’s symptoms worsened, pediatric otolaryngologists had to adapt quickly and coordinate care.
Related Articles
What’s The State of Biosimilars?
Drs. Eric Dein and Jonathan Kay discuss the state of biosimilars at the 2024 ACR Convergence meeting in Washington, DC.
Babywearing: What Is It and What Are the Benefits?
Any babywearing enthusiast can likely rattle off a laundry list of reasons they love this parenting practice. But what does the science say? A pediatrician…
J&J’s oral skin disease drug meets main goals of late-stage study
Johnson & Johnson’s oral drug for a type of skin condition met the main goals of achieving clear or almost clear skin and reduction in…
Merck licenses Chinese cancer drug, searching for next Keytruda blockbuster
Merck is licensing a new cancer drug from a Chinese firm, entering a buzzy field of oncology.
Dozens of stars backed Harris’s campaign and yet she lost. Is the era of celebrity endorsements over?
Focus on A-list talent such as Swift and Beyoncé may have reinforced an out-of-touch vision, or maybe celebrity support holds no political power
Alibaba, Nvidia collaborate on advanced autonomous-driving solution, computing services
Alibaba Group Holding’s cloud computing services unit and semiconductor powerhouse Nvidia are collaborating on an artificial intelligence (AI) initiative that will enable Chinese automakers to…
Medicine, not metrics: A value-based approach to Star Ratings
Improving Star Ratings lies in translating value-based care into terms that resonate with physicians, says Clover Health CEO Andrew Toy.
REIT Healthpeak Properties raises annual FFO forecast on steady demand
Healthpeak Properties , a U.S. healthcare-centric real estate investment trust, raised its annual forecast for funds from operations on Monday, betting on strong demand for…
What Exactly Are Phthalates? And Are They Safe?
These chemicals can be found everywhere, from plastics to personal care products. Learn more about how they interact with your hormones and what you can…
Health Rounds: Medication abortion also safe before 6 weeks of pregnancy
Medication abortions can be safely performed as early as the fourth week of pregnancy, researchers reported on Wednesday in The New England Journal of Medicine.